<DrugInformationSummary id="CDR0000495323"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>Paclitaxel albumin-stablilized nanoparticle formulation is a different form of the chemotherapy drug paclitaxel, which blocks cell division by interfering with microtubules (cellular structures that help move chromosomes during mitosis) and stopping mitosis (cell division). This eventually causes cells to die. The nanoparticle formulation allows higher doses to be given without increased side effects.Â 
</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/nanoparticlepaclitaxel">Paclitaxel Albumin-stabilized Nanoparticle Formulation</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000038690">nab-paclitaxel</TerminologyLink><GlossaryLink ref="CDR0000507600">paclitaxel albumin-stabilized nanoparticle formulation</GlossaryLink><USBrandNames><USBrandName>Abraxane</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>PA-klih-TAK-sil al-BYOO-min-STAY-bih-lized NA-noh-PAR-tih-kul for-myoo-LAY-shun</TermPronunciation><MediaLink ref="CDR0000718690" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000718691" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=24d10449-2936-4cd3-b7db-a7683db721e4&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Paclitaxel Albumin-stabilized Nanoparticle Formulation</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=24d10449-2936-4cd3-b7db-a7683db721e4&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Paclitaxel albumin-stabilized nanoparticle formulation is approved to be used alone or with other drugs to treat:</Para><ItemizedList Style="bullet" id="_5"><ListItem><Strong><GlossaryTermRef href="CDR0000444971" dictionary="Cancer.gov" audience="Patient">Breast cancer</GlossaryTermRef></Strong> that has  <GlossaryTermRef href="CDR0000045866" dictionary="Cancer.gov" audience="Patient">relapsed</GlossaryTermRef> or spread to other parts of the body after treatment with other chemotherapy. </ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000045323" dictionary="Cancer.gov" audience="Patient">Non-small cell lung cancer</GlossaryTermRef></Strong> that has spread. It is used with <GlossaryTermRef href="CDR0000045182" dictionary="Cancer.gov" audience="Patient">carboplatin</GlossaryTermRef> as the first treatment in patients whose cancer cannot be treated with surgery or <GlossaryTermRef href="CDR0000044971" dictionary="Cancer.gov" audience="Patient">radiation therapy</GlossaryTermRef>.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000044521" dictionary="Cancer.gov" audience="Patient">Pancreatic cancer</GlossaryTermRef></Strong> that has spread to other parts of the body. It is used with <GlossaryTermRef href="CDR0000508951" dictionary="Cancer.gov" audience="Patient">gemcitabine hydrochloride</GlossaryTermRef> as the first treatment.</ListItem></ItemizedList><Para id="_4">Paclitaxel albumin-stabilized nanoparticle formulation is also being studied in the treatment of other types of cancer.</Para><Para id="_7">Paclitaxel albumin-stabilized nanoparticle formulation is a form of <GlossaryTermRef href="CDR0000045258" dictionary="Cancer.gov" audience="Patient">paclitaxel</GlossaryTermRef> contained in <GlossaryTermRef href="CDR0000653131" dictionary="Cancer.gov" audience="Patient">nanoparticles</GlossaryTermRef> (very tiny particles of <GlossaryTermRef href="CDR0000046092" dictionary="Cancer.gov" audience="Patient">protein</GlossaryTermRef>). The drug is also called nanoparticle paclitaxel and protein-bound paclitaxel. This form may work better than other forms of paclitaxel and have fewer <GlossaryTermRef href="CDR0000046580" dictionary="Cancer.gov" audience="Patient">side effects</GlossaryTermRef>. For more information about paclitaxel that may apply to paclitaxel albumin-stabilized nanoparticle formulation, see the Drug Information Summary for <DrugRef href="CDR0000502187" url="/about-cancer/treatment/drugs/paclitaxel">Paclitaxel</DrugRef>.</Para></Section><Section id="_About"><Title>More About Paclitaxel Albumin-stabilized Nanoparticle Formulation</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/38690">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.5">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a619008.html">Paclitaxel Albumin-stabilized Nanoparticle Formulation</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.6"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.7">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C2688">Find Clinical Trials for Nab-paclitaxel</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2006-10-05</DateFirstPublished><DateLastModified>2024-12-13</DateLastModified></DrugInformationSummary>
